Key takeaways
Duoneb (ipratropium/albuterol) and Combivent Respimat (ipratropium/albuterol) are both used to treat chronic obstructive pulmonary disease (COPD) and contain the same active ingredients, but they differ in their form and administration. Duoneb is an inhalation solution that you use with a nebulizer, while Combivent Respimat is an inhaler, making it more convenient. Duoneb typically requires 4 doses a day, with each session taking up to 15 minutes, while Combivent Respimat also requires 4 doses a day but only takes a few seconds per dose. Both medications can cause similar side effects, such as lung problems and heart issues. Duoneb is available as a generic, making it a more affordable option, whereas Combivent Respimat is only available as a brand medication and can be expensive.
